Odor identification and Alzheimer disease biomarkers in clinically normal elderly
Matthew E. Growdon(Harvard University), Gad A. Marshall, Alexander Dagley(Athinoula A. Martinos Center for Biomedical Imaging), Mark W. Albers(Harvard University), Trey Hedden(Harvard University), Dorene M. Rentz(Brigham and Women's Hospital), Rebecca E. Amariglio(Harvard University), Reisa A. Sperling(Harvard University), Keith A. Johnson(Brigham and Women's Hospital), Aaron P. Schultz(Harvard University)
Cited by 159
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k